Polychromasia: Definition, Clinical Significance, and Laboratory Evaluation
Polychromasia represents young reticulocytes visible on Wright-stained peripheral blood smears, indicating active bone marrow response to anemia or blood loss, and should prompt immediate evaluation with a reticulocyte count to assess the appropriateness of marrow response.
What Polychromasia Indicates
Polychromatophilic erythrocytes are immature red blood cells that retain residual RNA, appearing blue-gray on routine Wright-Giemsa staining. These cells correspond specifically to Heilmeyer groups I, II, and III reticulocytes—the youngest reticulocyte populations 1. Their presence signals:
- Active erythropoiesis in response to anemia, hemolysis, or blood loss
- Adequate bone marrow function and erythropoietin response
- Recent red cell production within the past 1-2 days
The absence of polychromasia in an anemic patient is concerning and suggests inadequate marrow response, which may indicate:
- Bone marrow failure or suppression
- Nutritional deficiencies (iron, B12, folate)
- Insufficient erythropoietin production (as in chronic kidney disease)
- Inflammatory suppression of erythropoiesis
Essential Laboratory Tests to Order
When polychromasia is identified, order the following algorithmic workup:
First-Tier Tests (Order Immediately):
Complete Blood Count (CBC) with differential 2
- Evaluate all three cell lines (WBC, hemoglobin, platelets)
- Abnormalities in ≥2 cell lines warrant hematology consultation
- Mean corpuscular volume (MCV) helps categorize anemia type
Reticulocyte count (absolute and reticulocyte index) 2
- Confirms and quantifies the marrow response
- Reticulocyte index adjusts for degree of anemia
- Low count despite polychromasia suggests evolving process or inadequate response
Peripheral blood smear review 3, 4, 5, 6
- Look for: schistocytes (microangiopathic hemolysis), spherocytes (hemolysis), target cells (hemoglobinopathy/liver disease), bite cells (oxidative damage), basophilic stippling (lead poisoning, thalassemia)
- Assess degree of anisopoikilocytosis and polychromasia severity
Hemolysis markers (if hemolysis suspected) 4, 5, 6:
- Lactate dehydrogenase (LDH) - elevated
- Haptoglobin - decreased or undetectable
- Indirect (unconjugated) bilirubin - elevated
- Direct antiglobulin test (DAT/Coombs) - to exclude autoimmune hemolysis
Second-Tier Tests (Based on Initial Results):
If MCV is low (<80 fL) 2:
- Serum ferritin (tissue iron stores)
- Transferrin saturation (available iron for erythropoiesis)
- Consider hemoglobin electrophoresis or HPLC for thalassemia/hemoglobinopathy 3
If hemolysis is confirmed 4, 5:
- Direct antiglobulin test (if not already done)
- G6PD level (after acute episode resolves)
- Hemoglobin electrophoresis/HPLC for unstable hemoglobins 4
If cytopenias in multiple cell lines 6:
- Consider bone marrow biopsy
- Autoimmune workup if Evans syndrome suspected
Critical Pitfalls to Avoid
Do not assume polychromasia alone means adequate response: The reticulocyte count must be appropriately elevated for the degree of anemia. A "normal" reticulocyte count in severe anemia represents inadequate response 2.
Polychromasia in neonates has different reference ranges: Neonates normally have higher polychromasia and anisocytosis; use age-specific reference intervals 7.
Ferritin interpretation requires clinical context: In inflammatory states or chronic kidney disease, ferritin acts as an acute-phase reactant and may be falsely elevated despite true iron deficiency. Transferrin saturation is more reliable in these settings 2.
Do not delay treatment for confirmatory testing in life-threatening conditions: If thrombotic thrombocytopenic purpura (TTP) is suspected based on schistocytes, thrombocytopenia, and hemolysis, initiate plasma exchange before ADAMTS13 results return 5.
Shift reticulocytes (Heilmeyer groups I and II only) are more specific markers: These represent the youngest reticulocytes not found in normal circulation and better indicate acute marrow stress response than total reticulocyte counts 1.